In Silico Molecular Docking of Flavonoids from Vitex trifolia L. Leaves as Potential Inhibitors of EGFR Double Mutations
DOI:
https://doi.org/10.33096/pharmrep.v5i1.397Keywords:
Binding affinity, EGFR, flavonoid, molecular docking, phytochemical.Abstract
The Legundi plant (Vitex trifolia L.) is known to contain flavonoid compounds that exhibit potential anticancer activity through the inhibition of cancer cell growth. This study aimed to evaluate the binding affinity of flavonoid compounds from Vitex trifolia L. leaves against the epidermal growth factor receptor (EGFR) with double mutations (L858R/T790M) using a molecular docking approach. An in silico study was conducted by docking flavonoid compounds with the EGFR protein (PDB ID: 3IKA) using the AutoDock Vina program. A total of 14 flavonoid compounds were analyzed to assess their binding affinity and interaction profiles. The docking results revealed that the compound 2-(2,4-dimethoxyphenyl)-7-hydroxy-5-methoxy-2,3-dihydro- 4H-chromen-4-one (C18H18O6) exhibited the lowest binding free energy, indicating the strongest affinity toward the target receptor. Furthermore, the interaction analysis showed that this compound formed multiple types of interactions with the EGFR active site, including hydrogen bonds, hydrophobic interactions, van der Waals forces, and ionic interactions. These findings suggest that flavonoid compounds from Vitex trifolia L. have potential as inhibitors of EGFR double mutations and may serve as promising candidates for further development as anticancer agents.
References
Al-Mahrami, N., Nair, S. S. K., Al Mawali, A., Beema Shafreen, R. M., Ullah, S., Halim, S. A., Al-Harrasi, A., & Sivakumar, N. In-silico and in-vitro studies to identify potential inhibitors of SARS-CoV-2 spike protein from Omani medicinal plants. Heliyon, 2024; 10(21), e39649. https://doi.org/10.1016/j.heliyon.2024.e39649
Wati, A., Herman, H., Kosman, R., Utami, R. P., Ifdhollusyafaah, Sartika, A. A., ... & Fawwaz, M. In Vivo Anti‐Rheumatoid, Anti‐Inflammatory, and Analgesic Activities of Myristica fragrans Houtt With Docking Molecular Targeting TLR‐4 and HTRA‐1. ChemistrySelect, 2026; 11(7), e04440.
Fawwaz, M., Yusri, I., Pratama, M, Azizah, R.N., Gozal, R.A., et al. Molecular Insight, Antioxidant, and Cytotoxicity Evaluation of Vitex trifolia Leaves Against EGFR L858R/T790M and Wild Type in Lung Carcinoma. ChemistrySelect, 2025; 10(38), e00062. https://doi.org/10.1002/slct.202500062.
Fawwaz, M., Purwono, B., Sidiq, Y., Arwansyah, Arsul, M. I., Fitriana, ... & Baits, M. Anti‐inflammatory, Antioxidant, and Antibacterial Activities with Molecular Docking Studies of Vitex Trifolia L. Targeting Human COX‐2 and Peroxiredoxin‐5. ChemistrySelect, 2024; 9(39), e202403834.
Garbi, M., Osman, E., Dahab, M., Waleed, S., Ahmed, S., Awatif, A.E. Antigiardial , Antiamoebic and Cytotoxic Activity of the Leaves Extracts of Vitex trifolia, 2015, 1–7.
Mottaghipisheh, J., Kamali, M., Doustimotlagh, A. H., Nowroozzadeh, M. H., Rasekh, F., Hashempur, M. H., & Iraji, A. A comprehensive review of ethnomedicinal approaches, phytochemical analysis, and pharmacological potential of Vitex trifolia L. Frontiers in pharmacology, 2024, 15, 1322083.
Najib, A., Razak, R., Izzatul, M., 2023., Penambatan, Studi, Molekuler Senyawa, Tectoquinone Terhadap ‘The Creative Commons Attribution-ShareAlike 4.0 International License Enzim α-Glukosidase, Jurnal Fitofarmaka Indonesia, 2023; 10(2), 67, doi:10.33096/jffi.v10i2.964.
Najib, A., Fawwaz, M., Ismail, A., & Hamidu, L. In Silico Screening of Chemical Compound Activity as an α-Glucosidase Inhibitor from Sweet Flag Rhizome (Acorus calamus L.). Jurnal Fitofarmaka Indonesia, 2025; 12(3).
Rahmawati, R., Razak, R., & Fawwaz, M. Molecular Docking Study of Substituted Benzamide Derivatives as Analgesic Candidates. Borneo Journal of Pharmacy, 2025; 8(3), 242-251.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
- The author must submit Copyright form After acceptance of the article.
